- Investment Date
- November 2022
- Investment Type
Hilltop Leaf are leaders in the exciting development of a UK produced cannabis-based product for medicinal use in humans.
With research partnerships in place with Nottingham Trent University and the James Hutton Institute, Hilltop leaf have a strong focus on pharmaceutical quality control in a remote and secure location.
Why we chose to invest in Hilltop Leaf
Targeting market share of over 10% of the UK market, Hilltop Leaf have a strong multidisciplinary management team, a home office licence for production and a secure and EU GMP designed drying, extraction and processing factory in place. As the demand for medical cannabis gains momentum, and new benefits are uncovered for it’s use, we recognised the need to support domestic production of cannabis.
Scotland’s first medical cannabis facility raises £2m with Traditum. Read Here